Tamoxifen and risk of contralateral breast cancer in BRCA1 and BRCA2 mutation carriers: a case-control study. Hereditary Breast Cancer Clinical Study Group.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples